causal
Single-target therapies leave most tumor cells alive
Highly mutated tumors such as glioblastoma contain hundreds of mutations, so a targeted therapy that kills the subset carrying one mutation (illustrated as 20 percent) leaves the rest, which then grow, making most tumors not one target away from eradication.
causalpending
Speaker
BillEvidence Quote
“Let's say 20% of the cancer cells have that mutation that can be targeted. You kill those 20%, but then the 80% come in and they grow”
Created: 11/19/2026, 2:27:17 AM
Your notes
Loading notes...